The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling across histologies in lung cancer: Time to change WHO nomenclature?
 
Alessandro Russo
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer
 
Manana Javey
Employment - Roche Sequencing Solutions
 
Matthew Hiemenz
Employment - Foundation Medicine
 
Benjamin G Kaplan
Employment - Foundation Medicine
 
Stephanie J. Yaung
Employment - Roche Sequencing Solutions
 
Richard S.P. Huang
Employment - Roche/Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Patent on IHC; provisional patent on biomarkers and biomarker methodology.
 
Christian Diego Rolfo
Leadership - ELSEVIER; ESMO; European School Oncology; IASLC; International Society of Liquid Biopsy
Consulting or Advisory Role - Abbvie; Amgen; Aptitude Health; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Cor2Ed; Daiichi Sankyo Europe GmbH; Diverse Health Hub; EMD Serono; FLASCO; Guardant Health; Guardant Health; HMP Education; IDEOlogy Health; Imagene AI; Intellisphere; InVitae; Janssen Scientific Affairs; LUNGEVITY; Medical Education Consortium; MedStar Health; Merck Serono; MJH Live Events; Novartis; Novocure; Regeneron; ROCHE
Speakers' Bureau - Guardant Health; Roche Molecular Diagnostics
Research Funding - Lung Cancer Research Foundation
(OPTIONAL) Uncompensated Relationships - Guardant Health